Unknown

Dataset Information

0

Chemical genetics screening reveals KIAA1363 as a cytokine-lowering target.


ABSTRACT: Inflammation is a hallmark of many human diseases, including pain, arthritis, atherosclerosis, obesity and diabetes, cancer, and neurodegenerative diseases. Although there are several successfully marketed small molecules anti-inflammatory drugs such as cyclooxygenase inhibitors and glucocorticoids, many of these compounds are also associated with various adverse cardiovascular or immunosuppressive side effects. Thus, identifying novel anti-inflammatory small molecules and their targets is critical for developing safer and more effective next-generation treatment strategies for inflammatory diseases. Here, we have conducted a chemical genetics screen to identify small molecules that suppress the release of the inflammatory cytokine TNFα from stimulated macrophages. We have used an enzyme class-directed chemical library for our screening efforts to facilitate subsequent target identification using activity-based protein profiling (ABPP). Using this strategy, we have found that KIAA1363 is a novel target for lowering key pro-inflammatory cytokines through affecting key ether lipid metabolism pathways. Our study highlights the application of combining chemical genetics with chemoproteomic and metabolomic approaches toward identifying and characterizing anti-inflammatory smal molecules and their targets.

SUBMITTER: Hunerdosse DM 

PROVIDER: S-EPMC4273974 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5010250 | biostudies-literature
| S-EPMC7316778 | biostudies-literature
2020-05-25 | GSE145811 | GEO
| S-EPMC6866228 | biostudies-literature
| S-EPMC3190774 | biostudies-literature
| S-EPMC3684262 | biostudies-literature
2020-05-25 | PXD018270 | Pride
| S-EPMC6615456 | biostudies-literature
| S-EPMC4798878 | biostudies-literature
| S-EPMC6071712 | biostudies-literature